Integer Holdings Corporation

About Integer Holdings Corporation

Integer is a world leader in advanced medical device outsourcing, with an 80-year legacy of innovation and manufacturing excellence. The company focuses on providing high-quality medical device technologies and contract manufacturing services to global OEMs, enhancing patient lives through innovative solutions in cardiac rhythm, cardio and vascular health, and neuromodulation.

Products & Services

Batteries:Power solutions for medical devices including pacemaker and implantable batteries.

Capacitors:Tantalum capacitors for medical applications.

Catheters:Innovative catheter designs for various medical uses.

Class III Medical Device Systems:Advanced systems for critical medical applications.

Combined Devices:Integrated medical device solutions.

Complex Braiding and Formed Biomedical Structures:Specialized structures for biomedical applications.

Guidewires:Precision guidewires for medical procedures.

Introducers:Devices for facilitating medical access.

IPG Components:Components for implantable pulse generators.

Stents:Structural support devices for vascular applications.

Thin Wall Tubing, Composite Tubing, & Coated Wire:Specialized tubing and wire for medical devices.

Unfiltered & Filtered Feedthroughs:Components for secure electrical connections in medical devices.

Specialties

Advanced Medical Device Outsourcing Cardiac Rhythm Management Cardio and Vascular Health Neuromodulation Devices Custom Medical Battery Packs and Chargers Contract Development and Manufacturing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 1000000000 MR: - FA: 1.0 billion FAN: 1000000000	D: 2025-03-18 FD: 2025-03-18	-
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 875000000 MR: - FA: $875.0 million FAN: 875000000	D: 2025-03-13 FD: 2025-03-13	-
3	RT: Convertible Notes T: - FT: Convertible Notes	A: 750000000 MR: - FA: $750.0 million FAN: 750000000	D: 2025-03-12 FD: 2025-03-12	-
4	RT: Debt T: - FT: Debt	A: 300000000 MR: - FA: 300 million FAN: 300000000	D: 2024-07-01 FD: 2024-07-01	-
5	RT: Debt T: - FT: Debt	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2023-02-03 FD: 2023-02-03	-
6	RT: Debt T: - FT: Debt	A: 375000000 MR: - FA: $375 million FAN: 375000000	D: 2023-01-30 FD: 2023-01-30	-

Convertible Senior Notes Latest

2025-03-18

$1.0B

Convertible Debt 2025-03-13

$875.0M

Convertible Notes 2025-03-12

$750.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joseph W. Dziedzic

President & CEO

P

Payman Khales

Chief Operating Officer (COO), President & CEO Elect

D

Diron Smith

Executive Vice President, Chief Financial Officer

A

Andrew Senn

President, Cardio & Vascular

J

Jim Stephens

President, Cardiac Rhythm Management & Neuromodulation

J

John Harris

Executive Vice President, Global Operations and Manufacturing Strategy

View 7 more team members with Pro

Unlock Full Team Directory

Recent News